GSK announces £200 million investment in UK advanced manufacturing

GSKThe pharmaceutical giant GSK today announced a £200 million investment programme that it says will support a pipeline of new medicines and create a centre for pharmaceutical manufacturing innovation in the UK.

Manufacturing sites in Ware, Hertfordshire and Worthing, Sussex will be upgraded with new state-of-the-art equipment. In addition GSK said it will establish a new facility dedicated to harnessing innovative technologies “with the potential to transform both the way medicines are made and the company’s supply chain”.

GSK’s global manufacturing boss Roger Connor said the establishment of what the company calls ‘the Patent Box’ had transformed its view of the UK as a place to invest. He went on: “As a result, last year we announced we were building our first new factory in the UK for 40 years. The investments announced today are in addition to that and will allow us to harness new technologies that have the potential to deliver a step-change in how we make medicines. These new technologies could significantly reduce costs, improve quality and enable the manufacture of medicines in weeks rather than years and I am delighted that we have been able to bring these investments to the UK.”

The new investments comprise:

–  New manufacturing facilities in Ware for the latest inhaler devices.

–  In Worthing, a new bulk sterile building and filling line will be built for the company’s leading antibiotic medicine.

–  A new centre for manufacturing innovation will be built, dedicated to technologies ranging from mimicking nature to using nano-technologies. GSK’s preferred site for the location of the new centre is Ware, Hertfordshire where the company already has manufacturing and R&D facilities.

Copyright Ken Hurst 2013

Advertisements

About Ken Hurst

Ken Hurst began his career as a journalist in London over 30 years ago, working on a range of publications before moving on to weekly newspaper production in the newly-independent Zambia of the 1970s. He returned to the UK where his work included spells on newspapers and magazines, before moving to head up Norwich Union’s corporate affairs division. In the 1990s he moved on to freelance, co-own and publish the B2B audio magazine Sound and front the BBC radio Yesterday’s Papers programme. There followed six years as Business Editor at Britain’s biggest selling regional daily newspaper, The Eastern Daily Press, where he led an award-winning team and for whom he still writes a weekly socio/political comment column. Subsequently, he was Group Editorial Director at CBM, responsible for its UK and US magazine output – including The Manufacturer magazine – research-driven industry reports and live events content. Currently he is Contributing Editor at Works Management magazine publisher Findlay Media and Chairman of the consumer publishing house TNT Multimedia Ltd. He is a Fellow of the Royal Society of Arts and of the British Association of Communicators in Business.
This entry was posted in Manufacturing management, Moves/expansion, Pharma and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s